US20200055955A1

Fgl2 monoclonal antibodies and their use in treating malignant tumors

University of Texas System

Abstract

Provided herein are anti-FGL2 monoclonal antibodies. Further provided herein are methods to reverse suppressive immune mechanisms, such as for the treatment of cancer or infectious diseases.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Shulin Li
Priority date: May 05, 2017
Filing date: May 07, 2018
Publication date: February 20, 2020
Language: en
PDF source: https://patentimages.storage.googleapis.com/0f/5e/7d/10cfd6289c8046/US20200055955A1.pdf
Metadata fetched: August 29, 2026 00:27